Uveitis
MONDO:0020283An inflammatory process affecting a part of or the entire uvea. Causes include inflammatory agents (e.g., herpes simplex, herpes zoster, leptospirosis) and systemic diseases (e.g., inflammatory bowel disease, multiple sclerosis, systemic lupus erythematosus, ankylosing spondylitis). Patients present with pain and redness in the eye, light sensitivity, and blurred and decreased vision.
Also known as: inflammation of uvea, uvea inflammation, uveitis, uveitis (disease)
67 clinical trials for this condition and its sub-types, 37 tagged with Uveitis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Uveitis
-
Posterior uveitis 10 trials · 22 incl. sub-types
3 sub-types
- Retinitis 1 trial · 10 incl. sub-types Sub-types →
- Birdshot chorioretinopathy 2 trials
- Choroiditis 0 trials · 1 incl. sub-types Sub-types →
-
Anterior uveitis 8 trials · 20 incl. sub-types
3 sub-types
- Non-infectious anterior uveitis 7 trials Sub-types →
- Iridocyclitis 1 trial · 6 incl. sub-types Sub-types →
- Idiopathic anterior uveitis 0 trials
-
Panuveitis 6 trials · 9 incl. sub-types
4 sub-types
- Vogt-Koyanagi-Harada disease 2 trials
- Infectious panuveitis 1 trial
- Idiopathic panuveitis 0 trials Sub-types →
- Sympathetic ophthalmia 0 trials
-
Intermediate uveitis 8 trials
2 sub-types
- Hyalitis 0 trials
- Pars planitis 0 trials
-
Iritis 0 trials · 6 incl. sub-types
1 sub-type
- Iridocyclitis 1 trial · 6 incl. sub-types Sub-types →
-
Autoimmune uveitis 2 trials
-
Chorioretinitis 2 trials
4 sub-types
- Disseminated chorioretinitis 0 trials
- Focal chorioretinitis 0 trials Sub-types →
- Microcephaly and chorioretinopathy 0 trials Sub-types →
- Pars planitis 0 trials
-
Idiopathic posterior uveitis 1 trial
-
Suppurative uveitis 0 trials
Most studied deeper sub-types
-
New trial aims to stop CMV eye inflammation from returning
Disease control Not yet recruitingThis study tests whether oral valganciclovir or ganciclovir eye drops can reduce the virus causing eye inflammation and prevent flare-ups. About 117 adults with CMV anterior uveitis will receive either antiviral treatment or placebo for 7 days, then some continue for 12 months. T…
Phase 2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Could a simple blood test allow uveitis patients to safely take less medication?
Disease control Not yet recruitingThis trial investigates whether people with chronic non-infectious uveitis—an eye condition that can cause blindness—can safely reduce their dose of adalimumab (a drug that calms the immune system) by using regular blood tests to monitor drug levels. Participants whose uveitis ha…
Phase 4 • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New cell therapy trial aims to tame eye inflammation
Disease control Not yet recruitingThis early-stage study tests a one-time cell therapy called TRX103 for people with active non-infectious uveitis, a condition causing inflammation inside the eye. Up to 18 adults aged 18 to 70 will receive the treatment by IV and be monitored for a year. The main goal is to check…
Phase 1 • Sponsor: Quan Dong Nguyen • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New eye scanner could spot hidden signs of blindness
Diagnosis Not yet recruitingThis study will test a new, non-invasive eye scanner called wide field OCTA in 200 people with various eye diseases, including age-related macular degeneration, diabetic retinopathy, and dry eye. The goal is to see if this device can provide better images of blood vessels in the …
Sponsor: IRCCS San Raffaele • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC